Additionally, the 36-month beta value for GERN is 0.59. There are mixed opinions on the stock, with 1 analysts rating it as a “buy,” 0 rating it as “overweight,” 2 rating it as “hold,” and 0 rating it as “sell.”
The public float for GERN is 482.67M and currently, short sellers hold a 9.67% ratio of that float. The average trading volume of GERN on April 15, 2024 was 12.03M shares.
GERN) stock’s latest price update
The stock of Geron Corp. (NASDAQ: GERN) has decreased by -3.45 when compared to last closing price of 3.77. Despite this, the company has experienced a 9.64% gain in its stock price over the last five trading sessions. Business Wire reported 2024-04-03 that FOSTER CITY, Calif.–(BUSINESS WIRE)–Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced that John A. Scarlett, M.D., Geron’s Chairman and Chief Executive Officer, is scheduled to present at the following virtual investor conferences: 23rd Annual Needham Virtual Healthcare Conference Wednesday, April 10th at 10:15 a.m. ET (Fireside Chat) Stifel’s 2024 Virtual Targeted Oncology Days Wednesday, April 17th at 11:30 a.m. ET (Corporate Presentation) A.
GERN’s Market Performance
Geron Corp. (GERN) has experienced a 9.64% rise in stock performance for the past week, with a 93.62% rise in the past month, and a 75.00% rise in the past quarter. The volatility ratio for the week is 8.33%, and the volatility levels for the past 30 days are at 7.70% for GERN. The simple moving average for the past 20 days is 12.39% for GERN’s stock, with a 53.78% simple moving average for the past 200 days.
Analysts’ Opinion of GERN
Many brokerage firms have already submitted their reports for GERN stocks, with Needham repeating the rating for GERN by listing it as a “Buy.” The predicted price for GERN in the upcoming period, according to Needham is $5 based on the research report published on March 15, 2024 of the current year 2024.
Goldman, on the other hand, stated in their research note that they expect to see GERN reach a price target of $4. The rating they have provided for GERN stocks is “Buy” according to the report published on September 12th, 2023.
Goldman gave a rating of “Neutral” to GERN, setting the target price at $3 in the report published on March 28th of the previous year.
GERN Trading at 45.10% from the 50-Day Moving Average
After a stumble in the market that brought GERN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -3.86% of loss for the given period.
Volatility was left at 7.70%, however, over the last 30 days, the volatility rate increased by 8.33%, as shares surge +108.00% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +81.09% upper at present.
During the last 5 trading sessions, GERN rose by +9.64%, which changed the moving average for the period of 200-days by +18.57% in comparison to the 20-day moving average, which settled at $3.33. In addition, Geron Corp. saw 72.51% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at GERN starting from O’Farrell Elizabeth G., who purchase 6,607 shares at the price of $2.28 back on Aug 24 ’23. After this action, O’Farrell Elizabeth G. now owns 7,407 shares of Geron Corp., valued at $15,064 using the latest closing price.
O’Farrell Elizabeth G., the Director of Geron Corp., purchase 6,579 shares at $2.28 during a trade that took place back on Aug 24 ’23, which means that O’Farrell Elizabeth G. is holding 26,220 shares at $15,000 based on the most recent closing price.
Stock Fundamentals for GERN
Current profitability levels for the company are sitting at:
- -818.33 for the present operating margin
- -126.4 for the gross margin
The net margin for Geron Corp. stands at -776.71. The total capital return value is set at -0.68. Equity return is now at value -112.29, with -62.99 for asset returns.
Based on Geron Corp. (GERN), the company’s capital structure generated 0.25 points at debt to capital in total, while cash flow to debt ratio is standing at -2.02. The debt to equity ratio resting at 0.33. The interest coverage ratio of the stock is -46.4.
Currently, EBITDA for the company is -192.91 million with net debt to EBITDA at -0.08. When we switch over and look at the enterprise to sales, we see a ratio of 9094.07. The receivables turnover for the company is 0.14for trailing twelve months and the total asset turnover is 0.0. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.16.
Conclusion
In conclusion, Geron Corp. (GERN) has seen better performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
